Laryngeal Neoplasms: all 248 studies

Page 2 of 3. Open to participants first (64), then studies with results posted, then the rest; newest registration first within each.

• Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00410826Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00387335Phase 2Results posted
• Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)CompletedNCT00117572Phase 3Results posted
• Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00103259Phase 2Results posted
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00095628Phase 2Results posted
• Role of Cervical Fascia Flap in Decreasing the Incidence of Pharyngocutaneous Fistula After Total LaryngectomyCompletedNCT07241611Not applicable
• The Efficacy of Superficial Cervical Block Application in Postoperative Analgesia Management in Patients Undergoing Total Laryngectomy and Bilateral Neck DissectionCompletedNCT06852651Not applicable
• Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal CancerActive, not recruitingNCT06784401
• Thermotherapy for Locally Advanced Head and Neck CancerActive, not recruitingNCT06761937Phase 1
• Effect of Zinc and Probiotics Supplementation on Laryngeal Cancer Patients Undergoing Laryngectomy Surgery to Improve Prognosis and Better Wound HealingActive, not recruitingNCT06674564Not applicable
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCCActive, not recruitingNCT06295731Phase 2/3
• Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck CancerWithdrawnNCT06084845Phase 2
• Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose RadiotherapyActive, not recruitingNCT05992610Not applicable
• Efficacy of Adding Dexmedetomidine in Ultrasound-guided Intermediate Cervical Plexus Block for Thyroidectomy SurgeryCompletedNCT05814744Not applicable
• The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr SurvivorsCompletedNCT05798780Not applicable
• Bilateral Elective Neck Dissection in Salvage Total LaryngectomyCompletedNCT05746780
• Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT05721755Phase 3
• Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic CancerStatus unknownNCT05679856Not applicable
• A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After ChemoradiationWithdrawnNCT05512767Not applicable
• Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomyCompletedNCT05497947
• GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
• Feasibility Study CORPPSCompletedNCT05406024
• Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and EsophagitisCompletedNCT05369234Phase 3
• SpeakFree Heat and Moisture Exchanger (HME)CompletedNCT05349487Not applicable
• An Investigation of Biomarker Candidate Molecules in Laryngeal CarcinomaCompletedNCT05217147
• Optiflow vs. Convential Anesthesia During Pediatric Laryngeal Papilloma RemovalWithdrawnNCT05215249Phase 1/2
• Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
• Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and NeckActive, not recruitingNCT05172258Phase 2
• Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyActive, not recruitingNCT05075980Phase 2
• Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck CancersActive, not recruitingNCT05063552Phase 2/3
• A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
• Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerCompletedNCT04870840Phase 1
• Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT04862650Phase 2
• Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer TreatmentCompletedNCT04788264Not applicable
• Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell CancerCompletedNCT04778306Not applicable
• Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal LesionsStatus unknownNCT04777474Not applicable
• Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinActive, not recruitingNCT04533750Phase 1
• Phonosurgical Augmentation After Laser Resection of Early Glottic CarcinomaCompletedNCT04525066Phase 2
• IORT in Local Advanced LaryngocarcinomaStatus unknownNCT04278638Not applicable
• Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer PatientsStatus unknownNCT04174950Not applicable
• Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck CancerTerminatedNCT04110249Not applicable
• The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
• Cell-free Tumor DNA in Head and Neck Cancer PatientsStatus unknownNCT03942380Not applicable
• The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
• Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic CancerActive, not recruitingNCT03759431Phase 2
• Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal CancerStatus unknownNCT03747783
• Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct LaryngoscopyCompletedNCT03653039Not applicable
• Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal CarcinomaCompletedNCT03604601
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
• Nomograms to Precisely Predict Conditional Risk of Recurrence for Patients With Laryngeal CancerStatus unknownNCT03595410
• Characterization of the Autofluorescence of Healthy and Pathological Tissues of Vocal CordsCompletedNCT03585075
• Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/PharyngectomyTerminatedNCT03479463
• A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal CancerStatus unknownNCT03392220Not applicable
• Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.CompletedNCT03292341Not applicable
• Wound Complications in Head and Neck SurgeryCompletedNCT03134976
• Adaptive Radiotherapy for Head and Neck CancerCompletedNCT03096808Phase 2
• A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy PatientsStatus unknownNCT03039465Not applicable
• WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck CancerCompletedNCT03028766Phase 1
• A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
• Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck DissectionCompletedNCT02918955Phase 3
• Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal CancerCompletedNCT02849314Phase 1/2
• Dose Escalation Versus Standard in Laryngopharyngeal CancersCompletedNCT02757222Not applicable
• KTP vs CO2 Laser for the Treatment of Laryngeal CarcinomaStatus unknownNCT02672904Not applicable
• Confocal Laser Microlaryngoscopy (CLMx)WithdrawnNCT02628496Not applicable
• HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal CancerTerminatedNCT02464137Phase 1
• Irreversible Electroporation(IRE) For Unresectable Laryngeal NeoplasmsCompletedNCT02430675Not applicable
• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
• Olaparib and Radiotherapy in Head and Neck CancerActive, not recruitingNCT02229656Phase 1
• Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsCompletedNCT02217358Not applicable
• Pulsed Dye Laser in Treating Patients With Post Radiation DysphoniaCompletedNCT02198131Not applicable
• The Efficacy of Vocal Function Exercises for Laryngeal CancersCompletedNCT02156518Not applicable
• Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
• CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx CancerCompletedNCT01984502Phase 1
• Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNNCompletedNCT01884259Phase 2
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
• Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNCT01728480Phase 1
• Breath Testing in Early and Late Larynx CancerCompletedNCT01700647
• Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyWithdrawnNCT01674374Phase 2
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
• Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of LifeStatus unknownNCT01607138
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
• Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
• Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
• A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On CetuximabCompletedNCT01435252Phase 2
• TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
• Resistance Training and Physical Functioning in Head and Neck Cancer PatientsCompletedNCT01332682Phase 1
• Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
• Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
• Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic AssistanceCompletedNCT01257633
• Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck CancerTerminatedNCT01254734Not applicable
• Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
• TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck TumorsTerminatedNCT01245985Phase 2
• Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck CancerTerminatedNCT01216020Phase 2
• Study of Biomarker From Blood and Tissue of Head and Neck CarcinomaStatus unknownNCT01171235
• Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or ChemotherapyTerminatedNCT01164566Not applicable
• L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerCompletedNCT01155609Not applicable
• Pharmacogenetic Response to Chemotherapy Induction for ORL CancersCompletedNCT01104714
• Observational Study of Swallowing Function After Treatment of Advanced Laryngeal CancerCompletedNCT01089803

← Laryngeal Neoplasms overview